Coenen HH - Search Results

1

O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.

Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, Kurlemann G, Wassmann H, Coenen HH, Schober O. Weckesser M, et al. Among authors: coenen hh. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):422-9. doi: 10.1007/s00259-004-1705-8. Epub 2005 Jan 14. Eur J Nucl Med Mol Imaging. 2005. PMID: 15650870 Clinical Trial.

2

Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.

Pauleit D, Floeth F, Herzog H, Hamacher K, Tellmann L, Müller HW, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: coenen hh. Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):519-24. doi: 10.1007/s00259-003-1118-0. Epub 2003 Feb 15. Eur J Nucl Med Mol Imaging. 2003. PMID: 12589478

3

Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.

Pauleit D, Floeth F, Tellmann L, Hamacher K, Hautzel H, Müller HW, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: coenen hh. J Nucl Med. 2004 Mar;45(3):374-81. J Nucl Med. 2004. PMID: 15001676 Free article. Clinical Trial.

4

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.

Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Müller HW, Zilles K, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: coenen hh. Brain. 2005 Mar;128(Pt 3):678-87. doi: 10.1093/brain/awh399. Epub 2005 Feb 2. Brain. 2005. PMID: 15689365

5

PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.

Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, Herzog H, Bröer S, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: coenen hh. J Nucl Med. 2005 Mar;46(3):411-6. J Nucl Med. 2005. PMID: 15750152 Free article. Clinical Trial.

6

O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.

Langen KJ, Hamacher K, Weckesser M, Floeth F, Stoffels G, Bauer D, Coenen HH, Pauleit D. Langen KJ, et al. Among authors: coenen hh. Nucl Med Biol. 2006 Apr;33(3):287-94. doi: 10.1016/j.nucmedbio.2006.01.002. Nucl Med Biol. 2006. PMID: 16631076 Review.

7

Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?

Piroth MD, Liebenstund S, Galldiks N, Stoffels G, Shah NJ, Eble MJ, Coenen HH, Langen KJ. Piroth MD, et al. Among authors: coenen hh. Mol Imaging. 2013 Sep;12(6):388-95. Mol Imaging. 2013. PMID: 23981784

8

Quantification of the whole-body distribution of PET radiopharmaceuticals, applied to 3-N-([18F]fluoroethyl)spiperone.

Herzog H, Coenen HH, Kuwert T, Langen KJ, Feinendegen LE. Herzog H, et al. Among authors: coenen hh. Eur J Nucl Med. 1990;16(2):77-83. doi: 10.1007/BF01465913. Eur J Nucl Med. 1990. PMID: 2311622

9

3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.

Schmidt D, Gottwald U, Langen KJ, Weber F, Hertel A, Floeth F, Felsberg J, Reifenberger G, Coenen HH, Müller-Gärtner HW. Schmidt D, et al. Among authors: coenen hh. Eur J Nucl Med. 2001 Jul;28(7):855-61. doi: 10.1007/s002590100553. Eur J Nucl Med. 2001. PMID: 11504082

10

Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.

Salber D, Stoffels G, Pauleit D, Oros-Peusquens AM, Shah NJ, Klauth P, Hamacher K, Coenen HH, Langen KJ. Salber D, et al. Among authors: coenen hh. J Nucl Med. 2007 Dec;48(12):2056-62. doi: 10.2967/jnumed.107.046615. Epub 2007 Nov 15. J Nucl Med. 2007. PMID: 18006612 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters